Spots Global Cancer Trial Database for gynecologic neoplasms
Every month we try and update this database with for gynecologic neoplasms cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer | NCT05185947 | Gynecologic Can... Gynecologic Neo... Peritoneal Carc... Peritoneal Neop... Ovarian Cancer Ovarian Neoplas... Colorectal Canc... Colorectal Neop... Appendiceal Can... Appendiceal Neo... | Paclitaxel Nilotinib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | NCT02309944 | Postoperative C... Obesity Gynecologic Neo... | Standard Wound ... Prevena™ Incisi... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer | NCT03101280 | Gynecologic Neo... | Atezolizumab Rucaparib | 18 Years - | Hoffmann-La Roche | |
| Emerging From the Haze for Gynecologic Cancer Survivors | NCT02918461 | Gynecologic Neo... Cognition Disor... | Emerging from t... | 18 Years - | Cedars-Sinai Medical Center | |
| Thromboprophylaxis After Surgery for Gynecologic Malignancy in China | NCT02935530 | Gynecologic Neo... Venous Thromboe... Low Molecular W... Argatroban | s-LMWH LMWH Argatroban | 16 Years - 70 Years | Huazhong University of Science and Technology | |
| Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy | NCT02653469 | Gynecologic Neo... Abdominal Neopl... | Augmented venti... Fluid loading | 20 Years - 80 Years | Samsung Medical Center | |
| Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer | NCT00328757 | Gynecologic Neo... | Regular diet as... | 18 Years - 75 Years | Chiang Mai University | |
| Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients | NCT02309944 | Postoperative C... Obesity Gynecologic Neo... | Standard Wound ... Prevena™ Incisi... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor | NCT04042116 | Advanced Solid ... Gynecologic Can... | Lucitanib Lucitanib Lucitanib Nivolumab | 18 Years - | Clovis Oncology, Inc. | |
| A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer | NCT03101280 | Gynecologic Neo... | Atezolizumab Rucaparib | 18 Years - | Hoffmann-La Roche | |
| A Study to Evaluate Lucitanib in Combination With Nivolumab in Patients With a Solid Tumor | NCT04042116 | Advanced Solid ... Gynecologic Can... | Lucitanib Lucitanib Lucitanib Nivolumab | 18 Years - | Clovis Oncology, Inc. | |
| A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers | NCT02728830 | Gynecologic Neo... Epithelial Ovar... Uterine Endomet... Fallopian Tube ... Peritoneal Canc... | Pembrolizumab | 18 Years - | Duke University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
